How we help your company
business & staff timeline
Amalgamated 20+ years Synthetic Chemistry R&D, Scale-up, API & Intermediates manufacturing experience, WITH 15 years of Business Management in Sales, Marketing, collaborative deals and project management, TOGETHER with a formidable toolbox of chemical & process technology, INCLUDING unusual process specialities such as loop reactor, static flow, vapor phase & continuous reactions, SERVING commercial relationships to more than 500 western drug companies.
India & Word Health Organization Collaboration2011
Supported lead-in drug development and cost reduction activities for the WHO Global Malaria Programme. This has since become responsible for coordinating WHO’s global efforts to control and eliminate malaria. The work formed part of guidance by the Global Technical Strategy for Malaria 2016–2030 (GTS) adopted by the World Health Assembly in May 2015.
Plug-in to China Introduced.2012
Our experience, packaged into a “guidance” service to provide support for companies interested in working with Chinese CDMO’s. Whether to use China or stay domestic is the important decision that we support. Our team have helped hundreds of companies in the USA & Europe transition into a collaboration with China-based CRO/CMDO’s. It can be exceptionally beneficial, but daunting & risky. It is not necessarily the right choice, so let us guide you.
Boston & Cambridge Focus & HQ2015
It was a perfect match to center our support work in Boston and headquarter our business: Boston Biotech focuses on Drug Discovery & Development, and so do we. Over 1500 drug candidates in the pipelines of hundreds of small start-ups, executed by more than 30,000 R&D jobs, alongside established pharmaceutical incubators & world class research institutions is a collaborative ecosystem in which we decided to specialize amongst.
10th Pharma ClientJanuary 2017
The number of Clients we served, by supporting their R&D outsourcing activities reached double-digits.
Prospect, Win, Retain, Repeat LaunchMarch 2017
Our Customer Relationship Management (CRM) service designed specifically for CRO’s and CDMO’s in the pharma- R&D space. In a cost-effective manner, from pre-design strategy to post-deployment training, our CRM solutions deliver the functionality users expect and the flexibility a business needs to adapt and grow.
Our 7 year birthdayAugust 2017
Do you want to…
What our clients say
… we had critical milestones to reach and of course time was pressing. Our API synthesis was long and unoptimized. One day beyond the deadline could have cost our company another year in development. Their expericence is so well balanced with their focus on our goals, that they were successfully able to meet our needs by comprehension of the project’s intimately interconnected parts by reference to the whole …
… successful in closing the deal due to their attention to detail, prompt replies to our queries and excellent communication. They were attentive to our needs throughout the duration of the contract which resulted in a level of confidence …
… our sales team were losing opportunities to the competition and we couldn’t figure out why. Without saturating us with jargon and new processes BPS started to change the way we talked to our prospects. Six months later they transformed the way that we present our capabilities and proposals to our Clients …
… BPS training on their customized CRM platform was so simple that our field sales team immediately embraced it. We saw immediate benefits while previous initiatives were met with such resistance …
… the company immediately grasped the nature of our business and culture. I’m not sure if it was their experience or background research, but we were able to hold meaningful discussions from the outset without having educate them on what we needed …
Who we are:
We are a Boston-based company specializing in the CONFIDENTIAL execution of projects that support the Business and Technical Development of New Chemical Entities (NCE's) intended to provide important new therapies for patients.
- Ethical approach to our Clients Intellectual Property AND Funds.
- Extensive technical experience in chemical development for Pharmaceutical API's.
- Deep successful International experience with the CRO's and CDMO's.
- Skills that recognize the importance of decisions made implementing IND projects.
- Success in USA, Europe, China and India has underpinned our success in shortening timelines.
What we do:
You’ve reached the right place to acquire professional research, development & Pharmaceutical Quality/CMC support services.
Whether you want full-time project-specific support for several months, or just a couple of hours on a specific task, our flexible model allows or Clients to tap into an extensive network of innovators, technical experts, and seasoned professionals.
Intellectual Property (IP) is the most valuable asset in your Company. Awareness & security of our Clients IP is at the heart of our business: we’ll not only protect the value of our Clients assets through traceable Confidentiality Agreements and written Protocols, but we have a proven track record of enhancing the quality and value of this IP while our Clients maintain 100% of the developed IP when using Boston Pharmaceutical Support Services.
During the recruitment of our specialists we search for professionals with three core attributes that match our own at Boston Pharmaceutical Support, because our Clients will never love our company unless the employees love it first:
1: Personal characteristics that match the defined ethical values & core competencies of Boston Pharmaceutical Support.
2: Qualifications specific to the expert services that they support for our Clients.
3: Experience as mature professionals in the Drug Discovery and Drug Development community.
Thank You for visiting the Boston Pharmaceutical Support. Work with us soon.
Shire Stock Rising on Takeover Talks – TheStreet
Shire Stock Rising on Takeover Talks Amanda Schiavo Follow Jul 26, 2017 4:29 PM EDT Get TheStreet Quant Ratings’ exclusive 5-page report for (SHPG) – FREE. Shire is a biotech company that is focused on serving people with rare diseases and other specialized conditions. Shares of Shire PLC (SHPG) were gaining by more than 3% […]
Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector
Shares of Alexion Pharmaceuticals Inc. (ALXN) rose 6.7% to $139.88 in premarket trading on Thursday, July 27, after the New Haven, Conn.-based firm unveiled second-quarter results. Source: Alexion Spikes on Q2 Earnings Blowout Providing Positive Signs for Rest of Sector -Biotech Movers – TheStreet
Tetraphase Claws Back From Failed Study, Eyes FDA Filing With New Data
New data have given new life to Tetraphase Pharmaceuticals (NASDAQ: TTPH), which now has a shot to bring an experimental antibiotic to market despite a failed trial in the past.The Watertown, MA, company reported positive results late Tuesday in a 500-patient Phase 3 study of its lead antibiotic, eravacycline, in patients with complicated intra-abdominal infections […]